中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2013年
7期
815-818
,共4页
吉杰梅%陆华良%谷万杰%刘敬臣
吉傑梅%陸華良%穀萬傑%劉敬臣
길걸매%륙화량%곡만걸%류경신
G(M1)神经节苷脂%布比卡因%神经毒性%注射,脊髓
G(M1)神經節苷脂%佈比卡因%神經毒性%註射,脊髓
G(M1)신경절감지%포비잡인%신경독성%주사,척수
G(M1) ganglioside%Bupivacaine%Neurotoxicity%Injections,spinal
目的 评价鞘内注射单唾液酸神经节苷脂(GM-1)对布比卡因椎管麻醉诱发大鼠脊髓毒性的治疗效果.方法 健康成年雄性SD大鼠,体重280~300 g,于L3,4椎间隙向尾端行鞘内置管,取鞘内置管成功的大鼠144只,采用随机数字表法,将其分为4组(n=36):假手术组(S组)、GM-1组、布比卡因组(B组)和布比卡因+ GM-1组(BG组).B组和BG组鞘内注入5%布比卡因20μl,间隔1.5h给药1次,共3次,24 h后,BG组和GM-1组鞘内注射GM-1 20 μg,1次/d,连续7d.于鞘内注射布比卡因前及注射后1、3、5、7、14、28 d(T0-6)时测定甩尾反应潜伏期(TFL),计算最大抗辐射热效应(MPE)百分比,并行后肢运动功能评分(BBB评分);TFL和BBB评分测定后取脊髓组织,行HE染色,观察组织病理学改变,光镜和电镜下行组织损伤评分;采用免疫组化和RT-PCR法测定脊髓caspase-3蛋白及其mRNA表达水平.结果 与S组和GM-1组比较,B组T1-6时MPE百分比、组织损伤评分、脊髓caspase-3 mRNA和蛋白表达水平升高,BBB评分降低(P<0.05),BG组T1-5时MPE百分比升高(P<0.05),T6时恢复至基础值(P>0.05),T1-6时BBB评分降低,脊髓组织损伤评分、caspase-3 mRNA和蛋白表达水平升高(P<0.05).S组和GM-1组各时点各指标比较差异无统计学意义(P>0.05).与B组比较,BG组T2-6时MPE百分比、脊髓caspase-3 mRNA及蛋白表达水平降低,T3-6时脊髓组织损伤评分降低,T4-6时BBB评分升高(P<0.05).B组T1-6时脊髓组织病理学损伤明显,BG组T1-3时脊髓组织病理学损伤明显,T4-6时逐渐恢复.结论 鞘内注射GM-1对布比卡因椎管麻醉诱发大鼠脊髓毒性有治疗效果,其机制与抑制脊髓神经细胞凋亡有关.
目的 評價鞘內註射單唾液痠神經節苷脂(GM-1)對佈比卡因椎管痳醉誘髮大鼠脊髓毒性的治療效果.方法 健康成年雄性SD大鼠,體重280~300 g,于L3,4椎間隙嚮尾耑行鞘內置管,取鞘內置管成功的大鼠144隻,採用隨機數字錶法,將其分為4組(n=36):假手術組(S組)、GM-1組、佈比卡因組(B組)和佈比卡因+ GM-1組(BG組).B組和BG組鞘內註入5%佈比卡因20μl,間隔1.5h給藥1次,共3次,24 h後,BG組和GM-1組鞘內註射GM-1 20 μg,1次/d,連續7d.于鞘內註射佈比卡因前及註射後1、3、5、7、14、28 d(T0-6)時測定甩尾反應潛伏期(TFL),計算最大抗輻射熱效應(MPE)百分比,併行後肢運動功能評分(BBB評分);TFL和BBB評分測定後取脊髓組織,行HE染色,觀察組織病理學改變,光鏡和電鏡下行組織損傷評分;採用免疫組化和RT-PCR法測定脊髓caspase-3蛋白及其mRNA錶達水平.結果 與S組和GM-1組比較,B組T1-6時MPE百分比、組織損傷評分、脊髓caspase-3 mRNA和蛋白錶達水平升高,BBB評分降低(P<0.05),BG組T1-5時MPE百分比升高(P<0.05),T6時恢複至基礎值(P>0.05),T1-6時BBB評分降低,脊髓組織損傷評分、caspase-3 mRNA和蛋白錶達水平升高(P<0.05).S組和GM-1組各時點各指標比較差異無統計學意義(P>0.05).與B組比較,BG組T2-6時MPE百分比、脊髓caspase-3 mRNA及蛋白錶達水平降低,T3-6時脊髓組織損傷評分降低,T4-6時BBB評分升高(P<0.05).B組T1-6時脊髓組織病理學損傷明顯,BG組T1-3時脊髓組織病理學損傷明顯,T4-6時逐漸恢複.結論 鞘內註射GM-1對佈比卡因椎管痳醉誘髮大鼠脊髓毒性有治療效果,其機製與抑製脊髓神經細胞凋亡有關.
목적 평개초내주사단타액산신경절감지(GM-1)대포비잡인추관마취유발대서척수독성적치료효과.방법 건강성년웅성SD대서,체중280~300 g,우L3,4추간극향미단행초내치관,취초내치관성공적대서144지,채용수궤수자표법,장기분위4조(n=36):가수술조(S조)、GM-1조、포비잡인조(B조)화포비잡인+ GM-1조(BG조).B조화BG조초내주입5%포비잡인20μl,간격1.5h급약1차,공3차,24 h후,BG조화GM-1조초내주사GM-1 20 μg,1차/d,련속7d.우초내주사포비잡인전급주사후1、3、5、7、14、28 d(T0-6)시측정솔미반응잠복기(TFL),계산최대항복사열효응(MPE)백분비,병행후지운동공능평분(BBB평분);TFL화BBB평분측정후취척수조직,행HE염색,관찰조직병이학개변,광경화전경하행조직손상평분;채용면역조화화RT-PCR법측정척수caspase-3단백급기mRNA표체수평.결과 여S조화GM-1조비교,B조T1-6시MPE백분비、조직손상평분、척수caspase-3 mRNA화단백표체수평승고,BBB평분강저(P<0.05),BG조T1-5시MPE백분비승고(P<0.05),T6시회복지기출치(P>0.05),T1-6시BBB평분강저,척수조직손상평분、caspase-3 mRNA화단백표체수평승고(P<0.05).S조화GM-1조각시점각지표비교차이무통계학의의(P>0.05).여B조비교,BG조T2-6시MPE백분비、척수caspase-3 mRNA급단백표체수평강저,T3-6시척수조직손상평분강저,T4-6시BBB평분승고(P<0.05).B조T1-6시척수조직병이학손상명현,BG조T1-3시척수조직병이학손상명현,T4-6시축점회복.결론 초내주사GM-1대포비잡인추관마취유발대서척수독성유치료효과,기궤제여억제척수신경세포조망유관.
Objective To evaluate the efficacy of intrathecally administered monosialoganglioside (GM-1)for treatment of bupivacaine spinal anesthesia-induced neurotoxicity to rat spinal cord.Methods Adult male Sprague-Dawley rats,weighing 280-300 g,in which the intrathecal catheter was successfully inserted into the L3,4 intervertebral space and advanced toward the tail,were randomly divided into 4 groups (n =36 each):sham operation group (group S),GM-1 group,bupivacaine group (group B) and bupivacaine + GM-1 group (group BG).In B and BG groups,the rats received 5% bupivacaine 20 μl via the intrathecal catheter 3 times at 1.5-hour intervals.GM-1 20 μg was injected intrathecally 24 h later once a day for 7 days in BG and GM-1 groups.Before bupivacaine injection and on days 1,3,5,7,14 and 28 after bupivacaine injection (T0-T6),tail flick latency (TFL) was measured,MPE (percentage of maximal possible effect) was calculated,and the locomotor recovery was evaluated using the Basso,Beattie,Bresnahan (BBB) Locomotor Rating Scale.Then six rats were randomly chosen and sacrificed in each group.Spinal cord was removed for histopathologic examination (with light and electronic microscope) and for determination of caspase-3 protein and mRNA expression (by immuno-histochemistry and RTPCR).The pathological changes of the spinal cord were scored.Results Compared with S and GM-1 groups,MPE,pathological scores,and caspase-3 protein and mRNA expression were significantly increased and BBB score was decreased at T1-6 in group B (P < 0.05),and MPE was increased at T1-5 (P < 0.05) and returned to the baseline value at T6 (P > 0.05) and pathological scores,and caspase-3 protein and mRNA expression were significantly increased and BBB score was decreased at T1-6 in group BG (P < 0.05).There were no significant differences in each parameter at each time point between S and GM-1 groups (P > 0.05).Compared with group B,MPE and caspase-3 protein and mRNA expression were significantly decreased at T2-6,pathological scores were decreased at T3-6,and BBB score was increased at T4-6 in group BG (P < 0.05).The pathological changes of spinal cord tissues were obvious at T1-6 in group B and at T1-3 in group BG,but the changes gradually recovered at T4-6 in group BG.Conclusion Intrathecally administered GM-1 has therapeutic effect against bupivacaine spinal anesthesia-induced neurotoxicity to rat spinal cord,and inhibition of neuronal apoptosis in the spinal cord may be involved in the underlying mechanism.